Summary

In 2025, the global Pancrelipase market size was US$ 2,907 million and it will reach US$ 3,457 million in 2032, growing at CAGR of 2.99% between 2026 and 2032.
This report delivers a comprehensive overview of the global Pancrelipase market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pancrelipase. The Pancrelipase market size, estimates, and forecasts are provided in terms of sales volume (10 Billion LUE) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pancrelipase market comprehensively. Regional market sizes by Release Type, by End User, by Dosage Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pancrelipase manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Release Type, by End User, and by region.
Market Segmentation
By Company
 AbbVie
 Viatris
 Aimmune Therapeutics
 Abbott Laboratories
 BERLIN-CHEMIE
 Nordmark Pharma
 AVVA RUS
 Sun Pharma
 KRKA
 VIVUS
 Digestive Care
 Zentiva Pharma UK
 Essential Pharmaceuticals
 Biofarm SA
 OBNOVLENIE PFK
 Pharmbio Korea

Segment by Dosage Form
 Capsules
 Tablets
 Granules
 Powder

Segment by Release Type
 Delayed-Release
 Immediate-Release


Segment by Lipase Strength
 Low Strength
 Medium Strength
 High Strength


Segment by End User
 Cystic Fibrosis
 Chronic Pancreatitis
 Post-Surgical EPI
 Pancreatic Cancer
 Other

Consumption by Region
 North America
 U.S.
 Canada
 Asia-Pacific
 China
 Japan
 South Korea
 India
 Southeast Asia
 Europe
 Germany
 France
 U.K.
 Italy
 Russia
 Rest of Europe
 Latin America
 Mexico
 Brazil
 Argentina
 Middle East & Africa
 Turkey
 Saudi Arabia
 U.A.E


Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Release Type, by End User, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pancrelipase manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pancrelipase sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Dosage Form, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by End User, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Pancrelipase Market Overview 1
1.1 Product Definition 1
1.2 Pancrelipase by Dosage Form 2
1.2.1 Global Pancrelipase Market Value by Dosage Form: 2025 vs 2032 2
1.2.2 Capsules 3
1.2.3 Tablets 4
1.2.4 Granules 5
1.2.5 Other 5
1.3 Pancrelipase by Release Type 5
1.3.1 Global Pancrelipase Market Value by Release Type: 2025 vs 2032 5
1.3.2 Delayed-Release 6
1.3.3 Immediate-Release 7
1.4 Pancrelipase by Lipase Strength 8
1.4.1 Global Pancrelipase Market Value by Lipase Strength: 2025 vs 2032 8
1.4.2 Low Strength 8
1.4.3 Medium Strength 9
1.4.4 High Strength 9
1.5 Pancrelipase by End User 9
1.5.1 Global Pancrelipase Market Value by End User: 2025 vs 2032 9
1.5.2 Cystic Fibrosis 11
1.5.3 Chronic Pancreatitis 11
1.5.4 Post-Surgical EPI 11
1.5.5 Pancreatic Cancer 11
1.5.6 Other 11
1.6 Global Pancrelipase Market Size Estimates and Forecasts 12
1.6.1 Global Pancrelipase Revenue 2021–2032 12
1.6.2 Global Pancrelipase Sales 2021–2032 13
1.6.3 Global Pancrelipase Market Average Price (2021–2032) 14
1.7 Assumptions and Limitations 14

2 Pancrelipase Market Competition by Manufacturers 17
2.1 Global Pancrelipase Sales Market Share by Manufacturers (2021–2026) 17
2.2 Global Pancrelipase Revenue Market Share by Manufacturers (2021–2026) 20
2.3 Global Pancrelipase Average Price by Manufacturers (2021–2026) 23
2.4 Global Key Players of Pancrelipase, Industry Ranking, 2024 vs 2025 23
2.5 Global Key Manufacturers of Pancrelipase, Manufacturing Sites and Headquarters 24
2.6 Global Key Players of Pancrelipase, Product Types 25
2.7 Global Pancrelipase Market Competitive Situation and Trends 26
2.7.1 Global Pancrelipase Market Concentration Rate 26
2.7.2 The Top 5 and Top 10 Global Pancrelipase Players Market Share by Revenue 27
2.7.3 Global Pancrelipase Market Share by Company Tier (Tier 1, Tier 2, Tier 3) 28

3 Global Pancrelipase Market Scenario by Region 29
3.1 Global Pancrelipase Market Size by Region: 2021 vs 2025 vs 2032 29
3.2 Global Pancrelipase Sales by Region: 2021–2032 30
3.2.1 Global Pancrelipase Sales by Region: 2021–2026 30
3.2.2 Global Pancrelipase Sales by Region: 2027–2032 31
3.3 Global Pancrelipase Revenue by Region: 2021–2032 31
3.3.1 Global Pancrelipase Revenue by Region: 2021–2026 31
3.3.2 Global Pancrelipase Revenue by Region: 2027–2032 32
3.4 North America Pancrelipase Market Facts & Figures by Country 33
3.4.1 North America Pancrelipase Market Size by Country: 2021 vs 2025 vs 2032 33
3.4.2 North America Pancrelipase Sales by Country (2021–2032) 33
3.4.3 North America Pancrelipase Revenue by Country (2021–2032) 34
3.4.4 U.S. 34
3.4.5 Canada 35
3.5 Europe Pancrelipase Market Facts & Figures by Country 35
3.5.1 Europe Pancrelipase Market Size by Country: 2021 vs 2025 vs 2032 35
3.5.2 Europe Pancrelipase Sales by Country (2021–2032) 36
3.5.3 Europe Pancrelipase Revenue by Country (2021–2032) 36
3.5.4 Germany 37
3.5.5 France 38
3.5.6 U.K. 39
3.5.7 Italy 40
3.5.8 Russia 41
3.6 Asia Pacific Pancrelipase Market Facts & Figures by Region 41
3.6.1 Asia Pacific Pancrelipase Market Size by Region: 2021 vs 2025 vs 2032 41
3.6.2 Asia Pacific Pancrelipase Sales by Region (2021–2032) 42
3.6.3 Asia Pacific Pancrelipase Revenue by Region (2021–2032) 42
3.6.4 China 43
3.6.5 Japan 44
3.6.6 South Korea 44
3.6.7 India 45
3.6.8 Southeast Asia 45
3.7 Latin America Pancrelipase Market Facts & Figures by Country 46
3.7.1 Latin America Pancrelipase Market Size by Country: 2021 vs 2025 vs 2032 46
3.7.2 Latin America Pancrelipase Sales by Country (2021–2032) 46
3.7.3 Latin America Pancrelipase Revenue by Country (2021–2032) 47
3.7.4 Mexico 48
3.7.5 Brazil 49
3.7.6 Argentina 50
3.8 Middle East and Africa Pancrelipase Market Facts & Figures by Country 50
3.8.1 Middle East and Africa Pancrelipase Market Size by Country: 2021 vs 2025 vs 2032 50
3.8.2 Middle East and Africa Pancrelipase Sales by Country (2021–2032) 51
3.8.3 Middle East and Africa Pancrelipase Revenue by Country (2021–2032) 51
3.8.4 Turkey 52
3.8.5 Saudi Arabia 53
3.8.6 U.A.E 53

4 Segment by Dosage Form 54
4.1 Global Pancrelipase Sales by Dosage Form (2021–2032) 54
4.1.1 Global Pancrelipase Sales by Dosage Form (2021–2026) 54
4.1.2 Global Pancrelipase Sales by Dosage Form (2027–2032) 54
4.1.3 Global Pancrelipase Sales Market Share by Dosage Form (2021–2032) 54
4.2 Global Pancrelipase Revenue by Dosage Form (2021–2032) 55
4.2.1 Global Pancrelipase Revenue by Dosage Form (2021–2026) 55
4.2.2 Global Pancrelipase Revenue by Dosage Form (2027–2032) 55
4.2.3 Global Pancrelipase Revenue Market Share by Dosage Form (2021–2032) 56
4.3 Global Pancrelipase Price by Dosage Form (2021–2032) 56

5 Segment by End User 57
5.1 Global Pancrelipase Sales by End User (2021–2032) 57
5.1.1 Global Pancrelipase Sales by End User (2021–2026) 57
5.1.2 Global Pancrelipase Sales by End User (2027–2032) 57
5.1.3 Global Pancrelipase Sales Market Share by End User (2021–2032) 57
5.2 Global Pancrelipase Revenue by End User (2021–2032) 58
5.2.1 Global Pancrelipase Revenue by End User (2021–2026) 58
5.2.2 Global Pancrelipase Revenue by End User (2027–2032) 58
5.2.3 Global Pancrelipase Revenue Market Share by End User (2021–2032) 59
5.3 Global Pancrelipase Price by End User (2021–2032) 59

6 Key Companies Profiled 61
6.1 AbbVie 61
6.1.1 AbbVie Company Information 61
6.1.2 AbbVie Description and Business Overview 61
6.1.3 AbbVie Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 62
6.1.4 AbbVie Pancrelipase Product Portfolio 62
6.2 Viatris 63
6.2.1 Viatris Company Information 63
6.2.2 Viatris Description and Business Overview 64
6.2.3 Viatris Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 65
6.2.4 Viatris Pancrelipase Product Portfolio 65
6.3 Aimmune Therapeutics 66
6.3.1 Aimmune Therapeutics Company Information 66
6.3.2 Aimmune Therapeutics Description and Business Overview 66
6.3.3 Aimmune Therapeutics Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 67
6.3.4 Aimmune Therapeutics Pancrelipase Product Portfolio 68
6.4 Abbott Laboratories 69
6.4.1 Abbott Laboratories Company Information 69
6.4.2 Abbott Laboratories Description and Business Overview 69
6.4.3 Abbott Laboratories Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 70
6.4.4 Abbott Laboratories Pancrelipase Product Portfolio 70
6.5 BERLIN-CHEMIE 72
6.5.1 BERLIN-CHEMIE Company Information 72
6.5.2 BERLIN-CHEMIE Description and Business Overview 72
6.5.3 BERLIN-CHEMIE Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 73
6.5.4 BERLIN-CHEMIE Pancrelipase Product Portfolio 73
6.5.5 BERLIN-CHEMIE Recent Developments/Updates 74
6.6 Nordmark Pharma 75
6.6.1 Nordmark Pharma Company Information 75
6.6.2 Nordmark Pharma Description and Business Overview 75
6.6.3 Nordmark Pharma Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 76
6.6.4 Nordmark Pharma Pancrelipase Product Portfolio 76
6.7 AVVA RUS 78
6.7.1 AVVA RUS Company Information 78
6.7.2 AVVA RUS Description and Business Overview 79
6.7.3 AVVA RUS Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 79
6.7.4 AVVA RUS Pancrelipase Product Portfolio 80
6.7.5 AVVA RUS Recent Developments/Updates 81
6.8 Sun Pharma 81
6.8.1 Sun Pharma Company Information 81
6.8.2 Sun Pharma Description and Business Overview 82
6.8.3 Sun Pharma Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 83
6.8.4 Sun Pharma Pancrelipase Product Portfolio 83
6.9 KRKA 84
6.9.1 KRKA Company Information 84
6.9.2 KRKA Description and Business Overview 84
6.9.3 KRKA Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 85
6.9.4 KRKA Pancrelipase Product Portfolio 86
6.9.5 KRKA Recent Developments/Updates 87
6.10 VIVUS 87
6.10.1 VIVUS Company Information 87
6.10.2 VIVUS Description and Business Overview 88
6.10.3 VIVUS Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 89
6.10.4 VIVUS Pancrelipase Product Portfolio 89
6.10.5 VIVUS Recent Developments/Updates 90
6.11 Digestive Care 90
6.11.1 Digestive Care Company Information 90
6.11.2 Digestive Care Description and Business Overview 90
6.11.3 Digestive Care Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 91
6.11.4 Digestive Care Pancrelipase Product Portfolio 91
6.11.5 Digestive Care Recent Developments/Updates 92
6.12 Zentiva Pharma UK 92
6.12.1 Zentiva Pharma UK Company Information 92
6.12.2 Zentiva Pharma UK Description and Business Overview 93
6.12.3 Zentiva Pharma UK Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 94
6.12.4 Zentiva Pharma UK Pancrelipase Product Portfolio 94
6.12.5 Zentiva Pharma UK Recent Developments/Updates 94
6.13 Essential Pharmaceuticals 95
6.13.1 Essential Pharmaceuticals Company Information 95
6.13.2 Essential Pharmaceuticals Description and Business Overview 95
6.13.3 Essential Pharmaceuticals Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 96
6.13.4 Essential Pharmaceuticals Pancrelipase Product Portfolio 96
6.13.5 Essential Pharmaceuticals Recent Developments/Updates 97
6.14 Biofarm SA 97
6.14.1 Biofarm SA Company Information 97
6.14.2 Biofarm SA Description and Business Overview 98
6.14.3 Biofarm SA Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 99
6.14.4 Biofarm SA Pancrelipase Product Portfolio 99
6.14.5 Biofarm SA Recent Developments/Updates 100
6.15 OBNOVLENIE PFK 100
6.15.1 OBNOVLENIE PFK Company Information 100
6.15.2 OBNOVLENIE PFK Description and Business Overview 100
6.15.3 OBNOVLENIE PFK Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 101
6.15.4 OBNOVLENIE PFK Pancrelipase Product Portfolio 102
6.16 Pharmbio Korea 102
6.16.1 Pharmbio Korea Company Information 102
6.16.2 Pharmbio Korea Description and Business Overview 103
6.16.3 Pharmbio Korea Pancrelipase Sales, Revenue, and Gross Margin (2021–2026) 103
6.16.4 Pharmbio Korea Pancrelipase Product Portfolio 104
6.16.5 Pharmbio Korea Recent Developments/Updates 104

7 Industry Chain and Sales Channels Analysis 105
7.1 Pancrelipase Industry Chain Analysis 105
7.2 Pancrelipase Raw Material Supply Analysis 106
7.2.1 Key Raw Materials 106
7.2.2 Raw Materials Key Suppliers 107
7.3 Pancrelipase Production Mode & Process Analysis 107
7.4 Pancrelipase Sales and Marketing 109
7.4.1 Pancrelipase Sales Channels 109
7.4.2 Pancrelipase Distributors 110
7.5 Pancrelipase Customer Analysis 111

8 Pancrelipase Market Dynamics 112
8.1 Pancrelipase Industry Trends 112
8.2 Pancrelipase Market Drivers 112
8.3 Pancrelipase Market Challenges 113
8.4 Pancrelipase Market Restraints 114
8.5 Impact of U.S. Tariffs 115

9 Research Findings and Conclusion 117

10 Methodology and Data Source 118
10.1 Methodology/Research Approach 118
10.1.1 Research Programs/Design 118
10.1.2 Market Size Estimation 119
10.1.3 Market Breakdown and Data Triangulation 120
10.2 Data Source 121
10.2.1 Secondary Sources 121
10.2.2 Primary Sources 122
10.3 Author List 125
10.4 Disclaimer 125

ページTOPに戻る

List of Tables/Graphs

Table 1. Global Pancrelipase Market Value by Dosage Form (US$ Million), 2025 vs 2032 2
Table 2. Global Pancrelipase Market Value by Release Type (US$ Million), 2025 vs 2032 5
Table 3. Global Pancrelipase Market Value by Lipase Strength (US$ Million), 2025 vs 2032 8
Table 4. Global Pancrelipase Market Value by End User (US$ Million), 2025 vs 2032 9
Table 5. Global Pancrelipase Market Competitive Situation by Manufacturers in 2025 17
Table 6. Global Pancrelipase Sales (10 Billion LUE) of Key Manufacturers (2021–2026) 18
Table 7. Global Pancrelipase Sales Market Share by Manufacturers (2021–2026) 18
Table 8. Global Pancrelipase Revenue (US$ Million) by Manufacturers (2021–2026) 21
Table 9. Global Pancrelipase Revenue Share by Manufacturers (2021–2026) 21
Table 10. Global Market Pancrelipase Average Price (USD/10k LUE) of Key Manufacturers (2021–2026) 23
Table 11. Global Key Players of Pancrelipase, Industry Ranking, 2023 vs 2024 vs 2025 (US$ Million) 23
Table 12. Global Key Manufacturers of Pancrelipase, Manufacturing Sites and Headquarters 24
Table 13. Global Key Players of Pancrelipase, Product Types 25
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) 26
Table 15. Global Pancrelipase Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pancrelipase Revenue, 2025 28
Table 16. Global Pancrelipase Market Size by Region (US$ Million): 2021 vs 2025 vs 2032 29
Table 17. Global Pancrelipase Sales by Region (10 Billion LUE), 2021–2026 30
Table 18. Global Pancrelipase Sales Market Share by Region (2021–2026) 30
Table 19. Global Pancrelipase Sales by Region (10 Billion LUE), 2027–2032 31
Table 20. Global Pancrelipase Sales Market Share by Region (2027–2032) 31
Table 21. Global Pancrelipase Revenue by Region (US$ Million), 2021–2026 31
Table 22. Global Pancrelipase Revenue Market Share by Region (2021–2026) 32
Table 23. Global Pancrelipase Revenue by Region (US$ Million), 2027–2032 32
Table 24. Global Pancrelipase Revenue Market Share by Region (2027–2032) 32
Table 25. North America Pancrelipase Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million) 33
Table 26. North America Pancrelipase Sales by Country (10 Billion LUE), 2021–2026 33
Table 27. North America Pancrelipase Sales by Country (10 Billion LUE), 2027–2032 33
Table 28. North America Pancrelipase Revenue by Country (US$ Million), 2021–2026 34
Table 29. North America Pancrelipase Revenue by Country (US$ Million), 2027–2032 34
Table 30. Europe Pancrelipase Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million) 35
Table 31. Europe Pancrelipase Sales by Country (10 Billion LUE), 2021–2026 36
Table 32. Europe Pancrelipase Sales by Country (10 Billion LUE), 2027–2032 36
Table 33. Europe Pancrelipase Revenue by Country (US$ Million), 2021–2026 36
Table 34. Europe Pancrelipase Revenue by Country (US$ Million), 2027–2032 37
Table 35. Asia Pacific Pancrelipase Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million) 41
Table 36. Asia Pacific Pancrelipase Sales by Region (10 Billion LUE), 2021–2026 42
Table 37. Asia Pacific Pancrelipase Sales by Region (10 Billion LUE), 2027–2032 42
Table 38. Asia Pacific Pancrelipase Revenue by Region (US$ Million), 2021–2026 42
Table 39. Asia Pacific Pancrelipase Revenue by Region (US$ Million), 2027–2032 43
Table 40. Latin America Pancrelipase Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million) 46
Table 41. Latin America Pancrelipase Sales by Country (10 Billion LUE), 2021–2026 46
Table 42. Latin America Pancrelipase Sales by Country (10 Billion LUE), 2027–2032 46
Table 43. Latin America Pancrelipase Revenue by Country (US$ Million), 2021–2026 47
Table 44. Latin America Pancrelipase Revenue by Country (US$ Million), 2027–2032 47
Table 45. Middle East and Africa Pancrelipase Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million) 50
Table 46. Middle East and Africa Pancrelipase Sales by Country (10 Billion LUE), 2021–2026 51
Table 47. Middle East and Africa Pancrelipase Sales by Country (10 Billion LUE), 2027–2032 51
Table 48. Middle East and Africa Pancrelipase Revenue by Country (US$ Million), 2021–2026 51
Table 49. Middle East and Africa Pancrelipase Revenue by Country (US$ Million), 2027–2032 52
Table 50. Global Pancrelipase Sales (10 Billion LUE) by Dosage Form (2021–2026) 54
Table 51. Global Pancrelipase Sales (10 Billion LUE) by Dosage Form (2027–2032) 54
Table 52. Global Pancrelipase Sales Market Share by Dosage Form (2021–2026) 54
Table 53. Global Pancrelipase Sales Market Share by Dosage Form (2027–2032) 55
Table 54. Global Pancrelipase Revenue (US$ Million) by Dosage Form (2021–2026) 55
Table 55. Global Pancrelipase Revenue (US$ Million) by Dosage Form (2027–2032) 55
Table 56. Global Pancrelipase Revenue Market Share by Dosage Form (2021–2026) 56
Table 57. Global Pancrelipase Revenue Market Share by Dosage Form (2027–2032) 56
Table 58. Global Pancrelipase Price (USD/10k LUE) by Dosage Form (2021–2026) 56
Table 59. Global Pancrelipase Price (USD/10k LUE) by Dosage Form (2027–2032) 56
Table 60. Global Pancrelipase Sales (10 Billion LUE) by End User (2021–2026) 57
Table 61. Global Pancrelipase Sales (10 Billion LUE) by End User (2027–2032) 57
Table 62. Global Pancrelipase Sales Market Share by End User (2021–2026) 57
Table 63. Global Pancrelipase Sales Market Share by End User (2027–2032) 58
Table 64. Global Pancrelipase Revenue (US$ Million) by End User (2021–2026) 58
Table 65. Global Pancrelipase Revenue (US$ Million) by End User (2027–2032) 58
Table 66. Global Pancrelipase Revenue Market Share by End User (2021–2026) 59
Table 67. Global Pancrelipase Revenue Market Share by End User (2027–2032) 59
Table 68. Global Pancrelipase Price (USD/10k LUE) by End User (2021–2026) 59
Table 69. Global Pancrelipase Price (USD/10k LUE) by End User (2027–2032) 60
Table 70. AbbVie Company Information 61
Table 71. AbbVie Description and Business Overview 61
Table 72. AbbVie Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 62
Table 73. AbbVie Pancrelipase Product 62
Table 74. Viatris Company Information 63
Table 75. Viatris Description and Business Overview 64
Table 76. Viatris Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 65
Table 77. Viatris Pancrelipase Product 65
Table 78. Aimmune Therapeutics Company Information 66
Table 79. Aimmune Therapeutics Description and Business Overview 66
Table 80. Aimmune Therapeutics Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 67
Table 81. Aimmune Therapeutics Pancrelipase Product 68
Table 82. Abbott Laboratories Company Information 69
Table 83. Abbott Laboratories Description and Business Overview 69
Table 84. Abbott Laboratories Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 70
Table 85. Abbott Laboratories Pancrelipase Product 70
Table 86. BERLIN-CHEMIE Company Information 72
Table 87. BERLIN-CHEMIE Description and Business Overview 72
Table 88. BERLIN-CHEMIE Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 73
Table 89. BERLIN-CHEMIE Pancrelipase Product 73
Table 90. BERLIN-CHEMIE Recent Developments/Updates 74
Table 91. Nordmark Pharma Company Information 75
Table 92. Nordmark Pharma Description and Business Overview 75
Table 93. Nordmark Pharma Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 76
Table 94. Nordmark Pharma Pancrelipase Product 76
Table 95. AVVA RUS Company Information 78
Table 96. AVVA RUS Description and Business Overview 79
Table 97. AVVA RUS Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 79
Table 98. AVVA RUS Pancrelipase Product 80
Table 99. AVVA RUS Recent Developments/Updates 81
Table 100. Sun Pharma Company Information 81
Table 101. Sun Pharma Description and Business Overview 82
Table 102. Sun Pharma Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 83
Table 103. Sun Pharma Pancrelipase Product 83
Table 104. KRKA Company Information 84
Table 105. KRKA Description and Business Overview 84
Table 106. KRKA Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 85
Table 107. KRKA Pancrelipase Product 86
Table 108. KRKA Recent Developments/Updates 87
Table 109. VIVUS Company Information 87
Table 110. VIVUS Description and Business Overview 88
Table 111. VIVUS Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 89
Table 112. VIVUS Pancrelipase Product 89
Table 113. VIVUS Recent Developments/Updates 90
Table 114. Digestive Care Company Information 90
Table 115. Digestive Care Description and Business Overview 90
Table 116. Digestive Care Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 91
Table 117. Digestive Care Pancrelipase Product 91
Table 118. Digestive Care Recent Developments/Updates 92
Table 119. Zentiva Pharma UK Company Information 92
Table 120. Zentiva Pharma UK Description and Business Overview 93
Table 121. Zentiva Pharma UK Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 94
Table 122. Zentiva Pharma UK Pancrelipase Product 94
Table 123. Zentiva Pharma UK Recent Developments/Updates 94
Table 124. Essential Pharmaceuticals Company Information 95
Table 125. Essential Pharmaceuticals Description and Business Overview 95
Table 126. Essential Pharmaceuticals Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 96
Table 127. Essential Pharmaceuticals Pancrelipase Product 96
Table 128. Essential Pharmaceuticals Recent Developments/Updates 97
Table 129. Biofarm SA Company Information 97
Table 130. Biofarm SA Description and Business Overview 98
Table 131. Biofarm SA Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 99
Table 132. Biofarm SA Pancrelipase Product 99
Table 133. Biofarm SA Recent Developments/Updates 100
Table 134. OBNOVLENIE PFK Company Information 100
Table 135. OBNOVLENIE PFK Description and Business Overview 100
Table 136. OBNOVLENIE PFK Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 101
Table 137. OBNOVLENIE PFK Pancrelipase Product 102
Table 138. Pharmbio Korea Company Information 102
Table 139. Pharmbio Korea Description and Business Overview 103
Table 140. Pharmbio Korea Pancrelipase Sales (10 Billion LUE), Revenue (US$ Million), Price (USD/10k LUE), and Gross Margin (2021–2026) 103
Table 141. Pharmbio Korea Pancrelipase Product 104
Table 142. Pharmbio Korea Recent Developments/Updates 104
Table 143. Key Raw Materials Lists 106
Table 144. Raw Materials and Pharmaceutical Input Suppliers 107
Table 145. Pharmaceutical Wholesalers and Product Distribution Organizations 110
Table 146. Pancrelipase Market Trends 112
Table 147. Pancrelipase Market Drivers 113
Table 148. Pancrelipase Market Challenges 114
Table 149. Pancrelipase Market Restraints 115
Table 150. U.S. Pharmaceutical Tariff Framework 115
Table 151. Research Programs/Design for This Report 118
Table 152. Key Data Information from Secondary Sources 122
Table 153. Key Data Information from Primary Sources 123
Table 154. Authors List of This Report 125

List of Figures
Figure 1. Product Picture of Pancrelipase 1
Figure 2. Global Pancrelipase Market Value by Dosage Form (US$ Million), 2021–2032 2
Figure 3. Global Pancrelipase Market Share by Dosage Form: 2025 vs 2032 3
Figure 4. Capsules Product Picture 4
Figure 5. Tablets Product Picture 4
Figure 6. Global Pancrelipase Market Share by Release Type: 2025 & 2032 6
Figure 7. Delayed-Release Product Picture 7
Figure 8. Immediate-Release Product Picture 7
Figure 9. Global Pancrelipase Market Share by Lipase Strength: 2025 vs 2032 8
Figure 10. Global Pancrelipase Market Value by End User (US$ Million), 2021–2032 10
Figure 11. Global Pancrelipase Market Share by End User: 2025 & 2032 10
Figure 12. Global Pancrelipase Revenue, (US$ Million), 2021 vs 2025 vs 2032 12
Figure 13. Global Pancrelipase Market Size (US$ Million), 2021–2032 13
Figure 14. Global Pancrelipase Sales (10 Billion LUE), 2021–2032 13
Figure 15. Global Pancrelipase Average Price (USD/10k LUE), 2021–2032 14
Figure 16. Pancrelipase Report Years Considered 15
Figure 17. Pancrelipase Sales Share by Manufacturers in 2025 20
Figure 18. Global Pancrelipase Revenue Share by Manufacturers in 2025 22
Figure 19. Top 5 and Top 10 Global Pancrelipase Players: Market Share by Revenue in Pancrelipase in 2025 27
Figure 20. Global Pancrelipase Market Size by Region (US$ Million): 2021 -2032 30
Figure 21. U.S. Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 34
Figure 22. Canada Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 35
Figure 23. Germany Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 37
Figure 24. France Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 38
Figure 25. U.K. Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 39
Figure 26. Italy Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 40
Figure 27. Russia Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 41
Figure 28. China Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 43
Figure 29. Japan Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 44
Figure 30. South Korea Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 44
Figure 31. India Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 45
Figure 32. Southeast Asia Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 45
Figure 33. Mexico Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 48
Figure 34. Brazil Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 49
Figure 35. Argentina Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 50
Figure 36. Turkey Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 52
Figure 37. Saudi Arabia Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 53
Figure 38. U.A.E Pancrelipase Revenue Growth Rate (US$ Million), 2021–2032 53
Figure 39. CREON Picture 63
Figure 40. Pangrol Picture 74
Figure 41. Pankreatan Picture 78
Figure 42. Micrasim 81
Figure 43. Panlipase Capsule 84
Figure 44. Panzynorm forte-N 87
Figure 45. Triferment 99
Figure 46. Pancrelipase Value Chain 105
Figure 47. Pancrelipase Manufacturing Routes 109
Figure 48. Channels of Distribution (Direct Vs Distribution) 110
Figure 49. Bottom-up and Top-down Approaches for This Report 120
Figure 50. Data Triangulation 121
Figure 51. Key Executives Interviewed 123